Amgen (AMGN) Tops Q2 EPS by 14c, Raises FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Piper Jaffray Raises Price Target on Amgen (AMGN) to $200 Following 2Q EPS Beat
July 31, 2015 10:47 AM EDTPiper Jaffray reiterated an Overweight rating on Amgen (NASDAQ: AMGN), and raised the price target to $200.00 (from $192.00), following 2Q earnings results. Total revenue of $5.37B was ahead of consensus by $64M. EPS of $2.57 beat estimates by $0.16 aided by lower than expected R&D.... More
Amgen (AMGN) PT Raised to $193 at Cowen Post Q2
July 31, 2015 6:46 AM EDTCowen analyst Eric Schmidt reiterated an Outperform rating and boosted his price target on Amgen (NASDAQ: AMGN) to $193.00 (from $189.00) amid better-than-expected Q2 results.
Schmidt commented, "Amgen reported above-consensus Q2 revenue ($5.37B vs. $5.31BE) and non-GAAP EPS ($2.57 vs. $2.41E), and raised 2015 revenue... More
